CFG
IDXX icon

Clayton Financial Group’s Idexx Laboratories IDXX Stock Holding History

Clayton Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$2.81K – 309
2026
Q1 		$2.81K Hold
5
– – ﹤0.01% 412
2025
Q4 		$3.38K Buy
+5
New +$3.4K ﹤0.01% 375

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Clayton Financial Group's IDXX Position: Q2 2026 in Review

Clayton Financial Group sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 5 shares — an estimated $2.81K sold.

Clayton Financial Group first reported a position in IDXX in Q4 2025 and held it in 2 quarters. The position peaked at $3.38K in Q4 2025. 485 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Clayton Financial Group reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 5 Idexx Laboratories shares in Q2 2026, an estimated $2.81K.
  • Clayton Financial Group first reported a position in Idexx Laboratories in Q4 2025 and held it in 2 quarters.
  • Clayton Financial Group's Idexx Laboratories position peaked at $3.38K in Q4 2025.
  • 485 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.